These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 20526532)

  • 1. Regulation of Skp2 expression and activity and its role in cancer progression.
    Chan CH; Lee SW; Wang J; Lin HK
    ScientificWorldJournal; 2010 Jun; 10():1001-15. PubMed ID: 20526532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel roles of Skp2 E3 ligase in cellular senescence, cancer progression, and metastasis.
    Wang G; Chan CH; Gao Y; Lin HK
    Chin J Cancer; 2012 Apr; 31(4):169-77. PubMed ID: 22200179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Foxo3a transcription factor is a negative regulator of Skp2 and Skp2 SCF complex.
    Wu J; Lee SW; Zhang X; Han F; Kwan SY; Yuan X; Yang WL; Jeong YS; Rezaeian AH; Gao Y; Zeng YX; Lin HK
    Oncogene; 2013 Jan; 32(1):78-85. PubMed ID: 22310285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphorylation-dependent regulation of cytosolic localization and oncogenic function of Skp2 by Akt/PKB.
    Lin HK; Wang G; Chen Z; Teruya-Feldstein J; Liu Y; Chan CH; Yang WL; Erdjument-Bromage H; Nakayama KI; Nimer S; Tempst P; Pandolfi PP
    Nat Cell Biol; 2009 Apr; 11(4):420-32. PubMed ID: 19270694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting the oncogenic E3 ligase Skp2 in prostate and breast cancer cells with a novel energy restriction-mimetic agent.
    Wei S; Chu PC; Chuang HC; Hung WC; Kulp SK; Chen CS
    PLoS One; 2012; 7(10):e47298. PubMed ID: 23071779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphorylation of Ser72 does not regulate the ubiquitin ligase activity and subcellular localization of Skp2.
    Boutonnet C; Tanguay PL; Julien C; Rodier G; Coulombe P; Meloche S
    Cell Cycle; 2010 Mar; 9(5):975-9. PubMed ID: 20160482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular dynamics simulations elucidate the mode of protein recognition by Skp1 and the F-box domain in the SCF complex.
    Chandra Dantu S; Nathubhai Kachariya N; Kumar A
    Proteins; 2016 Jan; 84(1):159-71. PubMed ID: 26573739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Skp2 Pathway: A Critical Target for Cancer Therapy.
    Cai Z; Moten A; Peng D; Hsu CC; Pan BS; Manne R; Li HY; Lin HK
    Semin Cancer Biol; 2020 Dec; 67(Pt 2):16-33. PubMed ID: 32014608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The G1 phase E3 ubiquitin ligase TRUSS that gets deregulated in human cancers is a novel substrate of the S-phase E3 ubiquitin ligase Skp2.
    Jamal A; Swarnalatha M; Sultana S; Joshi P; Panda SK; Kumar V
    Cell Cycle; 2015; 14(16):2688-700. PubMed ID: 26038816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of Skp2 and its substrate CDKN1B (p27) in colorectal cancer.
    Bochis OV; Irimie A; Pichler M; Berindan-Neagoe I
    J Gastrointestin Liver Dis; 2015 Jun; 24(2):225-34. PubMed ID: 26114183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skp2 regulates the antiproliferative function of the tumor suppressor RASSF1A via ubiquitin-mediated degradation at the G1-S transition.
    Song MS; Song SJ; Kim SJ; Nakayama K; Nakayama KI; Lim DS
    Oncogene; 2008 May; 27(22):3176-85. PubMed ID: 18071316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of Skp2 levels by the Pim-1 protein kinase.
    Cen B; Mahajan S; Zemskova M; Beharry Z; Lin YW; Cramer SD; Lilly MB; Kraft AS
    J Biol Chem; 2010 Sep; 285(38):29128-37. PubMed ID: 20663873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysregulated expression of SKP2 and its role in hematological malignancies.
    Kulinski M; Achkar IW; Haris M; Dermime S; Mohammad RM; Uddin S
    Leuk Lymphoma; 2018 May; 59(5):1051-1063. PubMed ID: 28797197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of neddylation and deneddylation of cullin1 in SCFSkp2 ubiquitin ligase by F-box protein and substrate.
    Bornstein G; Ganoth D; Hershko A
    Proc Natl Acad Sci U S A; 2006 Aug; 103(31):11515-20. PubMed ID: 16861300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human CUL-1 associates with the SKP1/SKP2 complex and regulates p21(CIP1/WAF1) and cyclin D proteins.
    Yu ZK; Gervais JL; Zhang H
    Proc Natl Acad Sci U S A; 1998 Sep; 95(19):11324-9. PubMed ID: 9736735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of human CUL-1 and ubiquitin-conjugating enzyme CDC34 with the F-box protein p45(SKP2): evidence for evolutionary conservation in the subunit composition of the CDC34-SCF pathway.
    Lisztwan J; Marti A; Sutterlüty H; Gstaiger M; Wirbelauer C; Krek W
    EMBO J; 1998 Jan; 17(2):368-83. PubMed ID: 9430629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FBXO43 promotes cell cycle progression in cancer cells through stabilizing SKP2.
    Zheng L; Shen J; Chen Y; Lin J; Li P; Zhao X; Ren H; Sun Y; Wang Z
    Cancer Lett; 2024 Jun; 591():216848. PubMed ID: 38604312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skp2-Mediated Stabilization of MTH1 Promotes Survival of Melanoma Cells upon Oxidative Stress.
    Wang JY; Liu GZ; Wilmott JS; La T; Feng YC; Yari H; Yan XG; Thorne RF; Scolyer RA; Zhang XD; Jin L
    Cancer Res; 2017 Nov; 77(22):6226-6239. PubMed ID: 28947420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. E3 ubiquitin ligase Skp2 as an attractive target in cancer therapy.
    Hao Z; Huang S
    Front Biosci (Landmark Ed); 2015 Jan; 20(3):474-90. PubMed ID: 25553462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacogenomics and chemical library screens reveal a novel SCF
    Malek E; Abdel-Malek MA; Jagannathan S; Vad N; Karns R; Jegga AG; Broyl A; van Duin M; Sonneveld P; Cottini F; Anderson KC; Driscoll JJ
    Leukemia; 2017 Mar; 31(3):645-653. PubMed ID: 27677741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.